Eliem Therapeutics, Inc. (ELYM) has 11 open-market insider trades by 5 insiders since 2021. The most active filer is Valerie Morisset, CSO & VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Peter Kolchinsky | Dir10% Owner | — | 1 | $95.8M | 2024-06-27 |
| RA Capital Nexus Fund II, L.P. | Dir10% Owner | — | 1 | $40.0M | 2021-08-12 |
| Access Industries Holdings LLC | 10% Owner | — | 1 | $10.0M | 2021-08-12 |
| Valerie Morisset | CSOVP | — | 7 | $4.5M | 2024-07-22 |
| Emily Pimblett | CHIEF ACCOUNTING OFFICER | — | 1 | $9K | 2024-09-20 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Emily Pimblett | CHIEF ACCOUNTING OFFICER | Sell | $10K | 2024-09-20 |
| Valerie Morisset | CSO & VP | Sell | $1.4M | 2024-07-19 |
| Valerie Morisset | CSO & VP | Sell | $557K | 2024-07-17 |
| Valerie Morisset | CSO & VP | Sell | $357K | 2024-07-16 |
| Valerie Morisset | CSO & VP | Sell | $948K | 2024-07-12 |
| Valerie Morisset | CSO & VP | Sell | $737K |
Companies that share insiders with ELYM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-07-09 |
| Valerie Morisset | CSO & VP | Sell | $174K | 2024-07-05 |
| Valerie Morisset | CSO & VP | Sell | $338K | 2024-07-03 |
| Peter Kolchinsky | Director & 10% Owner | Buy | $95.8M | 2024-06-27 |
| Emily Pimblett | CHIEF ACCOUNTING OFFICER | Sell | $9K | 2024-06-20 |
| RA Capital Nexus Fund II, L.P. | Director & 10% Owner | Buy | $40.0M | 2021-08-12 |
| Access Industries Holdings LLC | 10% Owner | Buy | $10.0M | 2021-08-12 |